The findings extend our understanding of how adult brain plasticity is regulated by circulating factors and suggest that manipulating the post-translational acylation of plasma ghrelin may offer therapeutic opportunities to ameliorate cognitive decline in human neurodegenerative disease. Here, GHRL is linked to neurodegenerative disease.